Recently, the use of improved AdnaTest immune-magnetic systems also allowed the identification of CTC with stem-like features by PCR-based methods, showing that ALDH1 mainly contributed to CTC positivity compared to EPCAM, MUC1, or ERBB2 in bladder cancer patients [53]. This evidence concerns the gene ERBB2 and urinary bladder carcinoma.